These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34888358)

  • 21. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
    Zeisel SH; Warrier M
    Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
    Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
    J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
    Zhu Y; Li Q; Jiang H
    APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethylamine-
    Oakley CI; Vallejo JA; Wang D; Gray MA; Tiede-Lewis LM; Shawgo T; Daon E; Zorn G; Stubbs JR; Wacker MJ
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1272-H1282. PubMed ID: 32243768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
    Front Immunol; 2020; 11():574500. PubMed ID: 33042155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes.
    Steinke I; Ghanei N; Govindarajulu M; Yoo S; Zhong J; Amin RH
    Front Physiol; 2020; 11():567899. PubMed ID: 33192565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowiński A; Ufnal M
    Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD.
    Li X; Hong J; Wang Y; Pei M; Wang L; Gong Z
    Front Mol Biosci; 2021; 8():733507. PubMed ID: 34660695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut flora-dependent metabolite Trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress.
    Ke Y; Li D; Zhao M; Liu C; Liu J; Zeng A; Shi X; Cheng S; Pan B; Zheng L; Hong H
    Free Radic Biol Med; 2018 Feb; 116():88-100. PubMed ID: 29325896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases.
    Constantino-Jonapa LA; Espinoza-Palacios Y; Escalona-Montaño AR; Hernández-Ruiz P; Amezcua-Guerra LM; Amedei A; Aguirre-García MM
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
    Ivashkin VT; Kashukh YA
    Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
    [No Abstract]   [Full Text] [Related]  

  • 34. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
    Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Yokoro M; Ueda S; Wada Y; Takeuchi M; Shimizu M; Yamazaki H; Okuda S
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats.
    Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M
    Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.
    Thomas MS; Fernandez ML
    Curr Atheroscler Rep; 2021 Feb; 23(4):12. PubMed ID: 33594574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention.
    Chang YC; Chu YH; Wang CC; Wang CH; Tain YL; Yang HW
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
    Dambrova M; Latkovskis G; Kuka J; Strele I; Konrade I; Grinberga S; Hartmane D; Pugovics O; Erglis A; Liepinsh E
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.